β-herpesvirus (Human Cytomegalovirus and Human Herpesvirus 6) reactivation in at-risk lung transplant recipients and in human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 186, Issue 2, 2002, Pages 173-180

  Michaelides, Alexandra ^a,b   Glare, Eric M ^a   Spelman, Denis W ^b,c   Wesselingh, Steven L ^c,d   Hoy, Jennifer F ^c   Mijch, Anne M ^c   Kotsimbos, Thomas C ^a,d  

^a Respiratory Medicine   (Australia)

^b Veterinary Pathobiology   (Australia)

^c Bendigo Health   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS REACTIVATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOCOMPROMISED HOST; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; VIRUS ACTIVATION;

EID: 0037099187     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341456     Document Type: Article

References (36)

1. New strategies for the prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients
2. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients
3. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS
4. HHV-6 infection in HIV-infected asymptomatic and AIDS patients
5. Cytomegalovirus infection and pneumonitis: Impact after isolated lung transplantation
6. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus
7. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
8. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis
9. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients
10. Nonradioactive PCR-enzyme linked immunosorbent assay method for detection of human cytomegalovirus DNA
11. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes post lung transplantation correlates with HCMV pneumonitis
12. Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects
13. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients
14. Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood
15. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma
16. Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients
17. Seroconversion to human herpesvirus-6 following liver transplantation is a marker of HCMV disease
18. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation
19. Human herpesvirus-6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection
20. Human herpesvirus-6 in liver transplant recipients
21. Fever in liver transplant recipients: Changing spectrum of etiology agents
22. Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations
23. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients
24. Reactivation of human herpesvirus-6 by infection of human herpesvirus 7
25. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6
26. Human herpesvirus-6 infection after liver transplantation
27. Active HHV-6 infection in the lymph nodes of HIV-infected patients: In vitro evidence that HHV-6 can break HIV latency
28. Variant A human herpesvirus six as a cofactor in the pathogenesis of AIDS
29. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients
30. In vitro sensitivity of human herpesvirus 6 to antiviral drugs
31. Susceptibility of human herpesvirus 6 to antivirals in vitro
32. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir
33. Longitudinal study of human herpesvirus infection in organ transplant recipients
34. Human herpesvirus-6 infection and diseases following autologous and allogeneic bone marrow transplantation
35. Distribution of HHV-6 variants in human tissues
36. Infection of blood and bone marrow with the human cytomegalovirus in vivo